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Summary A 60-year-old woman with severe aortic stenosis (AS) and congenital bicuspid aortic
valve was admitted to our hospital due to cardiogenic pulmonary edema. Noninvasive adaptive
servo-ventilation (ASV) improved her symptoms and respiratory status. It was associated withHeart failure;
Cardiogenic
pulmonary edema
favorable hemodynamic effects including an increase in cardiac output and a decrease in pul-
monary vascular resistance without alternating systemic blood pressure. An improvement in
oxygenation and the favorable hemodynamic effects might lead to the stabilization of clinical
status. Noninvasive ventilation with ASV can avert tracheal intubation by improving oxygenation
and is expected to be convenient and useful in the treatment of acute pulmonary edema.
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Introduction
Acute cardiogenic pulmonary edema is a common medical
emergency. It is a leading cause of hospitalization and its
in-hospital mortality is as high as 10—20% [1,2]. Patients
who do not respond to initial therapy often require tracheal
intubation and ventilation, which may lead to respiratory
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omplications. Recently, noninvasive ventilation such as
ontinuous positive air way pressure (CPAP) or noninvasive
ntermittent positive pressure ventilation (NIPPV) has been
hown to avert tracheal intubation by improving oxygenation
ith favorable hemodynamic effects [3,4]. Adaptive servo-
entilation (ASV) has been widely accepted as one of the new
herapies for patients with heart failure, especially, with
heyne-Stokes respiration [5—9]. ASV has been postulated to
ave several physiological advantages compared to CPAP and
IPPV. ASV has low levels of background expiratory positive
irway pressure (EPAP) with variable levels of inspiratory
Published by Elsevier Ireland Ltd. All rights reserved.
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St. Jude Medical standard® bileaﬂet valve 23mm; St. Jude
Medical, St Paul, MN, USA) as an emergency. The surgical
operation was performed without any major complication,
and the postoperative course was favorable.
Table 1 Arterial blood gas analysis before and during adap-
tive servo-ventilation (ASV) (30min after the start of ASV
with oxygenation of 10 l/min) Before = before the adminis-
tration of 10 l/min oxygen with mask.
Before ASV During ASV
pH 7.463 7.408
pCO2 (mmHg) 52.7 54.3igure 1 (a) Chest X-ray on admission revealed prominent pu
hest X-ray during adaptive servo-ventilation (12 h later).
ositive airway pressure (IPAP) support which depends on the
espiratory status of each patient by automatic mechanical
ontrol [5]. Moreover, ASV is designed to reduce hyperven-
ilation by regulating minute ventilation within 90% of the
verage values during previous few minutes. Based on these
dvantages of ASV, it is expected that the noninvasive ven-
ilation by using ASV can be effective in the treatment of
cute cardiogenic pulmonary edema.
This is a report showing successful ASV therapy for a
atient with acute pulmonary edema associated with severe
ortic stenosis.
ase report
60-year-old woman diagnosed as having aortic stenosis (AS)
ith congenital bicuspid aortic valve was admitted to our
ospital due to worsening nocturnal dyspnea in July 2009.
n admission, her heart rate was 100 beats per minute
nd blood pressure was 104/68mmHg. She had irregular
ulse, loud diamond-shaped systolic ejection murmur at the
econd right sternal border which radiated to subclavicu-
ar region, and coarse crackles at both lungs. Chest X-ray
howed prominent pulmonary congestion and the enlarge-
ent of the heart (cardiothoracic ratio 64%) with pleural
ffusion (Fig. 1(a)). A 12-lead electrocardiogram (ECG)
evealed sinus rhythm with sporadic premature ventricular
eats and left ventricular (LV) hypertrophy. BNP was ele-
ated to 2743 pg/ml. She was treated with diuretics and
ow-dose phosphodiesterase (PDE) inhibitor parentally with
xygenation of 3 l/min through the nose. In spite of our ini-
ial treatment, she had worsening nocturnal dyspnea and
rthopnea.
Her respiratory rate was increased up to 34 times/min
nd oxygen saturation decreased to 95% despite the admin-
stration of 10 l/min oxygen with mask.
Moreover, arterial blood gas data revealed hypoxia (pO2
0.0mmHg) and hypercapnea (pCO2 52.7mmHg) in spite of
yperventilation due to massive pleural effusion (Table 1;
ig. 1(a)). In order to stabilize her respiratory status, ASV
as started with oxygenation of 10 l/min by using the Auto-
et CSR (Teijin Co, Tokyo, Japan) and full face masks (Teijinary edema and cardiac enlargement with pleural effusion. (b)
o) in default settings; EPAP of 5 cmH2O, IPAP of mini-
um 3 cmH2O, maximum 8—10 cmH2O. After 30min of ASV,
er symptoms greatly improved. Her respiratory rate was
tabilized to 15 times/min and oxygen saturation recov-
red to 99%. Moreover, arterial blood gas data revealed
mprovement of oxygenation (pO2 165.9mmHg) without
ajor alternation of pCO2 in parallel with stabilization of
he respiratory status (Table 1; Fig. 1(b)).
Moreover, ASV was associated with favorable hemo-
ynamic effects with oxygenation (Table 2). These data
howed an increase in cardiac output and stroke volume,
nd also the decrease in pulmonary vascular resistance and
ystemic vascular resistance without major changes in blood
ressure and heart rate during ASV. After stabilization, we
ould perform echocardiography and catheterization in a
upine position. Echocardiography revealed that aortic valve
rea (AVA) was 0.57 cm2 (Doppler method), peak LV-aorta
ressure gradient (LV-Ao PG) was 56mmHg, mean LV-Ao PG
as 34.3mmHg, and LV ejection fraction was 20% (Fig. 2).
oronary angiography revealed no signiﬁcant organic steno-
is. Therefore, we diagnosed her as having severe aortic
tenosis without ischemic heart disease, and then, per-
ormed surgical operation (aortic valve replacement; ThepO2 (mmHg) 60.1 165.9
HCO3− (mmol/l) 37.2 33.6
SPO2 (%) 95 100
Lactate (mg/dl) 9 7
Successful adaptive servo-ventilation for patients with acute car
Table 2 Hemodynamic data before and during adaptive
servo-ventilation (ASV).
Before ASV During ASV
HR (bpm) 101 106
BP (mmHg) 102/72 104/73
Mean BP 82.0 83.3
PAWP (mmHg) 20.0 18.0
Mean PAP (mmHg) 29.0 26.0
RAP (mmHg) 29.3 26.3
C.O. (l/min) 5.3 5.7
C.I. (l/min/m2) 2.9 3.2
SV (ml) 52.7 53.7
SVI (ml/m2) 28.9 30.2
SVR (dyn s cm−5) 950.9 916.5
SVRI (dyn s cm−5/m2) 1732.0 1632.5
PVR (dyn s cm−5) 140.4 116.5
PVRI (dyn s cm−5/m2) 255.7 207.5
SvO2 (%) 69.0 71.0
HR, heart rate; BP, blood pressure; PAWP, pulmonary artery
wedge pressure; PAP, pulmonary arterial pressure; RAP, right
atrial pressure; C.O., cardiac output; C.I., cardiac index; SV(I),
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mstroke volume (index); SVR(I), systemic vascular resistance
(index); PVR(I), pulmonary vascular resistance (index); SvO2,
mixed venous oxyhemoglobin saturation.
Discussion
This report demonstrated that noninvasive ventilation using
ASV is useful for the treatment of a patient with acute
cardiogenic pulmonary edema due to severe aortic steno-
sis. Tracheal intubation and mechanical ventilation using
sedatives are frequently required for the stabilization of
respiratory status in patients with acute pulmonary edema.
However, these procedures may increase the risk for car-
diogenic shock and respiratory complication. If once the
patient with severe aortic stenosis should develop cardio-
genic shock, it is sometimes very hard to improve the
hemodynamic status even with the use of intra-aortic bal-
loon pumping (IABP) and percutaneous cardiopulmonary
support (PCPS).
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Figure 2 Transthoracic echocardiography. (a) Short-axis view shows
of cusps. (b) Color Doppler reveals severe aortic stenosis with maxim
area was calculated as 0.57 cm2.diogenic pulmonary edema e117
Gray et al. reported that noninvasive ventilation such
s CPAP or NIPPV induced a more rapid improvement in
espiratory distress and metabolic disturbance than stan-
ard oxygen therapy in patients with acute cardiogenic
ulmonary edema [10]. Moreover, noninvasive methods of
entilation could avert tracheal intubation by improving
xygenation, reducing the work of breathing, and increas-
ng cardiac output due to preload and afterload reduction
nd improvement of the oxygenation [11—13]. Increases in
ntrathoracic pressure could decrease LV afterload and aug-
ent LV ejection. The important hemodynamic effects of
SV are the preload reduction due to the decrease in exces-
ive venous return via an increase in intrathoracic pressure
y EPAP (5 cm) and the afterload reduction through the
ecrease in myocardial transmural pressure gradient. These
eneﬁcial effects of both preload and afterload reduction
nd the maintenance of those in good balance by ASV might
ead to its favorable hemodynamics. Especially, in patients
ith hypervolemic heart failure, this prominent afterload
educing effect can result in improved LV ejection, increased
ardiac output, and reduced myocardial oxygen demand, all
f which can be seen by the use of IABP [14]. Furthermore,
SV can improve oxygen delivery to the tissue by increasing
ardiac output as well as oxygenation [15]. As a result, ASV
an lead to the improvement of clinical status of the patient
ith cardiogenic pulmonary edema.
The present report suggests that ASV is similarly effec-
ive as noninvasive methods of ventilation such as NIPPV or
PAP in patients with cardiogenic pulmonary edema. More-
ver, it should be emphasized that ASV has several important
dvantages compared to other conventional methods of
oninvasive ventilation. NIPPV performs forced ventilation
ith constant pressure regardless of the respiration of the
atient. Moreover, the delicate and complicated adjust-
ents of positive airway pressure setting or titration are
eeded for each patient. Therefore, conventional NIPPV
ight not only disturb the therapeutic adherence or accept-
bility for the patient with heart failure, but also increase
he activity of sympathetic nerve, which may induce fatal
ardiac arrhythmias. On the other hand, ASV can support the
reathing of the pressure wave form similar to spontaneous
espiration and maintain 90% of the average minute ventila-
the bicuspid aortic valve with calciﬁcation and limited opening
al pressure gradient of 56mmHg across aortic valve and valve
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ion during most recent 3min by regulating IPAP and timing
f the backup support automatically based on the default
echanical setting, which may minimize the activation of
ympathetic activity. In fact, as for our patient who received
SV therapy, the respiratory status and the hemodynamics
ere drastically improved and clearly stabilized thereafter
n our patient. Moreover, fatal cardiac arrhythmia never
ccurred during ASV therapy. ASV was quite convenient and
seful for the patient with cardiogenic pulmonary edema.
owever, we could not perform polysomnography before and
uring ASV for this patient because of her poor condition.
e thus need to acknowledge this point as a limitation that
e could not precisely evaluate the effects of ASV on the
pnea-hypopnea index (AHI) and the status of Cheyne-Stokes
espiration associated with heart failure. Moreover, we could
ot determine the superiority of ASV directly compared to
ther noninvasive methods of ventilation or its mechanisms.
onclusion
SV is one of the most useful and safe therapies in noninva-
ive ventilation for acute cardiogenic pulmonary edema.
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